# Prophylactic Analgesia for Bladder Botox Injections

> **NCT06514430** · PHASE4 · WITHDRAWN · sponsor: **Montefiore Medical Center**

## Conditions studied

- Urinary Incontinence
- Urinary Incontinence, Urge
- Overactive Bladder

## Interventions

- **DRUG:** Phenazopyridine
- **DRUG:** 1% lidocaine with sodium bicarbonate

## Key facts

- **NCT ID:** NCT06514430
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-07
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** It was determined that it would be impracticable to conduct this study as a randomized trial. Study has been repurposed as a non-randomized study.
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06514430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06514430, "Prophylactic Analgesia for Bladder Botox Injections". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06514430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*